Three types of self-efficacy associated with medication adherence in patients with co-occurring HIV and substance use disorders, but only when mood disorders are present

被引:16
|
作者
Reif, Susan [1 ]
Proeschold-Bell, Rae Jean [1 ,2 ]
Yao, Jia [1 ]
LeGrand, Sara [1 ,2 ]
Uehara, Anna [2 ]
Asiimwe, Edgar [2 ]
Quinlivan, Evelyn Byrd [3 ]
机构
[1] Duke Univ, Duke Ctr Hlth Policy & Inequal Res, Durham, NC USA
[2] Duke Univ, Duke Global Hlth Inst, 2812 Erwin Rd,Suite 403, Durham, NC 27705 USA
[3] Univ North Carolina Chapel Hill, Ctr Infect Dis, Chapel Hill, NC USA
来源
JOURNAL OF MULTIDISCIPLINARY HEALTHCARE | 2013年 / 6卷
关键词
human immunodeficiency virus; self-efficacy; substance use; depression; anxiety; interventions;
D O I
10.2147/JMDH.S44204
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Adherence with medication regimens for human immunodeficiency virus (HIV) is a life-saving behavior for people with HIV infection, yet adherence is challenging for many individuals with co-occurring substance use and/or mood disorders. Medication-taking self-efficacy, which is the confidence that one can take one's medication as prescribed, is associated with better adherence with HIV medication. However, little is known about the influence that other kinds of self-efficacy have on adherence with HIV medication, especially among HIV-infected individuals with co-occurring substance use and/or mood disorders. We sought to examine the relationship between adherence with HIV medication among substance users and three specific kinds of self-efficacy, ie, one's confidence that one can communicate with medical providers, get support, and manage one's mood. We further sought to examine whether symptoms of depression and anxiety moderate these relationships. Methods: Patients were recruited from three HIV clinics in the southeastern United States as part of an integrated study of treatment for HIV and substance use. Results: We interviewed 154 patients with HIV and substance use who reported taking HIV medications. Based on symptoms of depression and anxiety using the Patient Health Questionnaire-9 and the Hospital Anxiety and Depression Scale-Anxiety, 63% had probable depression and/or anxiety. Higher levels of self-efficacy in provider communication (beta = 3.86,P < 0.01), getting needed support (beta = 2.82, P < 0.01), and mood management (beta = 2.29, P < 0.05) were related to better self-reported adherence with HIV medication among study participants with probable depression and/or anxiety. The three kinds of self-efficacy were not associated with medication adherence among participants with HIV and substance use only. Conclusion: In the search for mutable factors to improve medication adherence among individuals triply diagnosed with HIV, substance use, and mood disorders, these findings support previous research indicating the benefit of enhancing self-efficacy, and further point to three specific kinds of self-efficacy that may benefit medication adherence, ie, provider communication, getting support, and mood management.
引用
收藏
页码:229 / 237
页数:9
相关论文
共 50 条
  • [31] TOOLS AND TECHNIQUES TO IMPROVE THE ASSESSMENT AND TREATMENT OF CO-OCCURRING SUBSTANCE USE DISORDERS IN YOUR PATIENTS
    Galanter, Cathryn A.
    Busch, Gerald
    Shankar, Ravi
    Hsiao, Ray
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2023, 62 (10): : S426 - S427
  • [32] Internalized stigma, self-efficacy and treatment motivation in patients with substance use disorders
    Bozdag, Neslihan
    Cuhadar, Dondu
    JOURNAL OF SUBSTANCE USE, 2022, 27 (02) : 174 - 180
  • [33] Network Analysis of DSM Symptoms of Substance Use Disorders and Frequently Co-Occurring Mental Disorders in Patients with Substance Use Disorder Who Seek Treatment
    Lopez-Toro, Edith
    Wolf, Casper J. H.
    Gonzalez, Rafael A.
    van den Brink, Wim
    Schellekens, Arnt
    Velez-Pastrana, Maria C.
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (10)
  • [34] THE DIFFERENTIAL EFFECTS OF ALCOHOL AND CANNABIS ON MOOD STATES IN A SAMPLE OF YOUTH WITH CO-OCCURRING MENTAL HEALTH AND SUBSTANCE USE DISORDERS
    Neumann, Chelsea L.
    Reichenberg, Jared L.
    Graves, Hannah R.
    Nestor, Bridget A.
    Gomez, Judelysse
    Wolff, Jennifer C.
    Spirito, Anthony
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2016, 55 (10): : S146 - S147
  • [35] Victimization and clinical outcomes among HIV-infected individuals with co-occurring mental and substance use disorders
    Hanisch, Laura J.
    Ostermann, Jan
    Palmer, Steven C.
    Reif, Susan S.
    Thielman, Nathan
    Whetten, Kathryn
    ANNALS OF BEHAVIORAL MEDICINE, 2008, 35 : S45 - S45
  • [36] Co-occurring substance use disorders among patients with opioid use disorder in rural primary care clinics
    Zhu, Yuhui
    Baldwin, Laura-Mae
    Mooney, Larissa J.
    Saxon, Andrew J.
    Kan, Emily
    Hser, Yih-Ing
    JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT, 2024, 158
  • [37] Association of co-occurring opioid or other substance use disorders with increased healthcare utilization in patients with depression
    Veer Vekaria
    Budhaditya Bose
    Sean M. Murphy
    Jonathan Avery
    George Alexopoulos
    Jyotishman Pathak
    Translational Psychiatry, 11
  • [38] Association of co-occurring opioid or other substance use disorders with increased healthcare utilization in patients with depression
    Vekaria, Veer
    Bose, Budhaditya
    Murphy, Sean M.
    Avery, Jonathan
    Alexopoulos, George
    Pathak, Jyotishman
    TRANSLATIONAL PSYCHIATRY, 2021, 11 (01)
  • [39] Co-Occurring Psychiatric and Substance Use Disorders: Clinical Survey Among a Rural Cohort of Italian Patients
    Milano, Giulia
    Vergani, Hayley M.
    Cattedra, Simone
    Carrozzino, Roberto
    Mattioli, Francesca
    Robbiano, Luigi
    Martelli, Antonietta
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2019, 15 : 3453 - 3459
  • [40] A short term pilot group for patients with co-occurring psychosis in partial remission and substance use disorders
    Kucina, A. Uzmah
    Delic, M.
    Avgustin, B.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S499 - S500